Page last updated: 2024-08-26

cilastatin and Colonic Neoplasms

cilastatin has been researched along with Colonic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abe, Y; Aoki, N; Arita, M; Goto, S; Hayashi, M; Hokari, S; Hosojima, M; Ichikawa, K; Kabasawa, H; Kikuchi, T; Kondo, R; Koya, T; Kuwahara, S; Nozaki, K; Ohshima, Y; Ohtsubo, A; Saito, A; Sato, M; Shoji, S; Suzuki, R; Takahashi, M; Watanabe, S1
Cho, HJ; Kim, BY; Kim, JT; Kim, JW; Kim, TW; Lee, CH; Lee, HG; Lee, SJ; Lee, Y; Lim, JS; Park, SY; Yeom, YI1

Other Studies

2 other study(ies) available for cilastatin and Colonic Neoplasms

ArticleYear
Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity.
    Scientific reports, 2021, 01-12, Volume: 11, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cilastatin; Cisplatin; Colonic Neoplasms; Female; Glomerular Filtration Rate; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Inbred NOD; Mice, SCID; Renal Insufficiency; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2021
Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer.
    Oncotarget, 2016, Feb-23, Volume: 7, Issue:8

    Topics: Animals; Antigens, CD; Cadherins; Cell Adhesion; Cell Line, Tumor; Cilastatin; Colonic Neoplasms; Dipeptidases; Epithelial-Mesenchymal Transition; Female; GPI-Linked Proteins; HCT116 Cells; HT29 Cells; Humans; Leukotriene D4; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transforming Growth Factor beta; Transplantation, Heterologous

2016